We have located links that may give you full text access.
Dyspepsia and Helicobacter pylori: test, treat or investigate?
The annual prevalence of dyspepsia in the UK is about 25%. Dyspepsia is one of the most common reasons for a patient to visit a primary care physician (PCP), accounting for between 3 and 4% of all PCP consultations. Antisecretory drugs prescribed by PCPs to relieve dyspepsia consume over 7% of the annual UK National Health Service drugs budget. In patients < 45 years old and in the absence of sinister symptoms (weight loss, anorexia or gastrointestinal blood loss) or treatment with non-steroidal anti-inflammatory drugs, three conditions account for the majority of cases of dyspepsia, namely functional (non-ulcer) dyspepsia (up to 60%), gastroesophageal reflux (5-15%) and peptic ulcer disease (15-25%). The discovery of Helicobacter pylori and its association with peptic ulcer disease led to a reevaluation of the management strategies used for dyspepsia. It became possible, using non-invasive testing, to determine whether a patient with dyspepsia was colonized with H. pylori and if not, it made peptic ulcer disease most unlikely. There are four main strategies for the management of patients with dyspepsia: empiric treatment, 'test and treat', 'test and investigate', or simply 'investigate'. The advantages, disadvantages and possible outcomes using each of these strategies are discussed using an evidence-based approach.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app